Renal Cell Carcinoma: A Case Series with Integrative TreatmentMiranda Costa*, Elena Panutich and Heather Zwickey
National College of Natural Medicine, Helfgott Research Institute, 2220 SW 1st Ave, Portland, OR 97201, USA
- *Corresponding Author:
- Miranda Costa
National College of Natural Medicine
Helfgott Research Institute, 2220 SW 1st Ave, Portland
OR 97201, USA
E-mail: [email protected]
Received date:: December 10, 2015 Accepted date:: January 04, 2016 Published date:: January 15, 2016
Citation: Costa M, Panutich E, Zwickey H (2016) Renal Cell Carcinoma: A Case Series with Integrative Treatment. J Integr Oncol S1:002. doi:10.4172/2329-6771.S1-002
Copyright: © 2016 Costa M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: Renal cell carcinoma (RCC) is a rare and difficult to treat cancer. The case series aimed to observe the effects of medicinal mushrooms and integrative oncology care for renal cell carcinoma.
Clinical Features: Patients diagnosed with RCC who were being treated with surgery and chemotherapy and were administered integrative treatment in the form of supplements and medicinal mushrooms and/or combinations of mushrooms.
Interventions and outcomes: Integrative care included a combination of supplements and the medicinal mushrooms Ganoderma lucidum, Trametes versicolor, Cordyceps sinensis, Grifola frondosa, and Lentinus edodes in combination or alone, which was initiated following adjuvant care. These patients experienced increased overall survival compared to standard adjuvant treatment alone.
Conclusion: Beneficial effects of integrative care were observed in this case series. Disease progression and symptoms related to adjuvant treatment were significantly decreased in these patients after integrative supportive care was initiated and effects persisted through the final observation period. Further controlled studies are needed among larger groups of patients to determine the clinical efficacy of medicinal mushrooms and integrative oncology in the treatment of RCC.